Regulation of Natural Killer cell cytotoxicity by shedding of the Fc receptor CD16

Katja Srpan,Adam N. R. Cartwright,Daniel M Davis

DOI: https://doi.org/10.4049/jimmunol.196.supp.126.8

2016-05-01

The Journal of Immunology

Abstract:Abstract Natural Killer (NK) cells are cytotoxic lymphocytes that can recognize and kill virally infected or tumour transformed cells by the secretion of cytolytic granules containing perforin. An individual NK cell can kill several target cells sequentially. Each target cell can trigger NK cell activation via different activating ligands and here we report that the order in which ligands are encountered affects the NK cell response. When NK cells are repeatedly activated via their Fc receptor CD16, with the therapeutic antibody rituximab, perforin secretion decreases with each stimulation. However, perforin secretion is restored to its initial level upon subsequent activation by MICA, which ligates NKG2D. Repeated stimulation of NK cells via MICA also decreases the degranulation capacity of NK cells but, strikingly, this effect cannot be rescued by a subsequent stimulation with rituximab. We found that the mechanism underlying these differential outcomes involves shedding of CD16, which occurs upon NK cell activation through both CD16 and NKG2D. Shedding of CD16 renders the cells insensitive to further activation via that receptor but they remain competent for further activation by NKG2D. We also found that NK cells are more motile on rituximab-coated surfaces than on MICA-coated surfaces and their migration speed decreases upon inhibition of CD16 shedding. Thus, although CD16 shedding hinders NK cell responsiveness it can serve to augment NK cell motility to move between target cells. Together these data indicate that manipulation of CD16 shedding might be an important target for NK cell-based therapies including treatments with therapeutic antibodies.

immunology